Daniel S Greenspan

USPTO Granted Patents = 8 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 18(Granted Patents)

Company Filing History:

8 out of 4,132

Wisconsin Alumni Research Foundation

patents

1 out of 3,692

Johns Hopkins University

where one patent can have more than one assignee

Years Active: 1999-2011

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7888313 - Composition for treating a fibrotic disorder comprising an inhibitor of a BMP-1-like protein (2011-02-15),

2. 7572599 - Metalloprotease activation of myostatin, and methods of modulating myostatin activity (2009-08-11),

3. 6759528 - Mammalian pro-&agr;3(V) collagen chain genes (2004-07-06),

4. 6579702 - Mammalian tolloid-like gene and protein (2003-06-17),

5. 6297011 - Mammalian tolloid-like gene and protein (2001-10-02),

6. 6037139 - System for assaying modulators of procollagen maturation (2000-03-14),

7. 5981717 - Mammalian tolloid-like gene and protein (1999-11-09),

8. 5939321 - Mammalian tolloid-like gene and protein (1999-08-17),

Title: The Innovations of Daniel S. Greenspan

Introduction

Daniel S. Greenspan is a notable inventor based in Madison, WI (US), recognized for his contributions to the field of biomedical research. With a total of 8 patents to his name, he has made significant strides in developing treatments for various fibrotic disorders and muscle growth modulation.

Latest Patents

Among his latest patents is a composition for treating a fibrotic disorder that comprises an inhibitor of a BMP-1-like protein. This invention includes α-macroglobulin-related agents aimed at treating or preventing fibrotic disorders associated with fibrillogenesis. Additionally, he has developed methods for using these agents and producing them for therapeutic applications. Another significant patent involves the metalloprotease activation of myostatin, where it has been determined that metalloprotease cleavage of a myostatin pro peptide activates a latent inactive form of myostatin. This patent provides methods for identifying agents that modulate this activation and offers strategies for modulating muscle growth in organisms by manipulating metalloprotease-mediated cleavage.

Career Highlights

Daniel has worked with prominent organizations such as the Wisconsin Alumni Research Foundation and The Johns Hopkins University. His work in these institutions has allowed him to advance his research and contribute to innovative solutions in the biomedical field.

Collaborations

Throughout his career, Daniel has collaborated with esteemed colleagues, including Kazuhiko Takahara and Guy G. Hoffman. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking inventions.

Conclusion

Daniel S. Greenspan's innovative work and patents reflect his dedication to advancing medical science and improving treatment options for fibrotic disorders and muscle growth. His contributions continue to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.